Bank of America
STLNW

Bank of America’s Starling Oncology, Inc. Warrant STLNW Stock Holding History

Bank of America’s Portfolio STLNW Stock Details STLNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-200
Closed -$1 – 8560
2024
Q4 		$1 Sell
200
-299
-60% -$5 ﹤0.01% 8149
2024
Q3 		$10 Sell
499
-400
-44% -$8 ﹤0.01% 8046
2024
Q2 		$23 Buy
899
+699
+350% +$54 ﹤0.01% 7977
2024
Q1 		$40 Hold
200
– – ﹤0.01% 7458
2023
Q4 		$25 Buy
+200
New +$32 ﹤0.01% 7618
2023
Q2 		– Sell
-100
Closed -$6 – 7943
2023
Q1 		$6 Buy
+100
New +$12 ﹤0.01% 7670

Other funds holding STLNW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
AGM
Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3% 1-Year Est. Return
FL
FreeGulliver LLC New Orleans, Louisiana $237M AUM 21.92% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return

Bank of America's STLNW Position: Q1 2025 in Review

Bank of America sold out of Starling Oncology, Inc. Warrant (STLNW) in Q1 2025, closing a stake of 200 shares — an estimated $1 sold.

Bank of America first reported a position in STLNW in Q1 2023 and held it in 6 quarters. The position peaked at $40 in Q1 2024. 11 funds tracked by Wall St. Rank hold STLNW as of Q1 2025.

  • Bank of America reported no remaining Starling Oncology, Inc. Warrant position as of Q1 2025 after selling out during the quarter.
  • Bank of America sold 200 Starling Oncology, Inc. Warrant shares in Q1 2025, an estimated $1.
  • Bank of America first reported a position in Starling Oncology, Inc. Warrant in Q1 2023 and held it in 6 quarters.
  • Bank of America's Starling Oncology, Inc. Warrant position peaked at $40 in Q1 2024.
  • 11 funds tracked by Wall St. Rank held Starling Oncology, Inc. Warrant as of Q1 2025.

Based on Bank of America's 13F filing for Q1 2025, filed 15 May 2025.